Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.

[1]  R. Ramesh,et al.  RNA Binding Proteins (RBPs) and their role in DNA Damage and radiation response in cancer. , 2022, Advanced drug delivery reviews.

[2]  C. Sette,et al.  DNA Damage Regulates the Functions of the RNA Binding Protein Sam68 through ATM-Dependent Phosphorylation , 2022, Cancers.

[3]  Shi-Yuan Cheng,et al.  DNA damage and metabolic mechanisms of cancer drug resistance , 2022, Cancer drug resistance.

[4]  W. Vermeij,et al.  Chemotherapy Side-Effects: Not All DNA Damage Is Equal , 2022, Cancers.

[5]  Bo He,et al.  LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells , 2022, Bioengineered.

[6]  W. El-Deiry,et al.  Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents , 2021, International journal of molecular sciences.

[7]  R. Fåhraeus,et al.  p53 mRNA Metabolism Links with the DNA Damage Response , 2021, Genes.

[8]  Feng Yan,et al.  Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1 , 2021, NPJ breast cancer.

[9]  Stéphanie Panier,et al.  New Faces of old Friends: Emerging new Roles of RNA-Binding Proteins in the DNA Double-Strand Break Response , 2021, Frontiers in Molecular Biosciences.

[10]  Wen Xu,et al.  ADAMTS9-AS2: A functional long non-coding RNA in tumorigenesis. , 2021, Current pharmaceutical design.

[11]  Yuanyuan Huang,et al.  Noncoding RNAs involved in DNA Methylation and Histone methylation, and acetylation in Diabetic Vascular Complications. , 2021, Pharmacological research.

[12]  Xiaozhong Peng,et al.  A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome , 2021, Signal Transduction and Targeted Therapy.

[13]  Liqiu Zou,et al.  Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO. , 2020, Acta biochimica et biophysica Sinica.

[14]  Ziwei Huang,et al.  Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma , 2020, Cell Death & Disease.

[15]  Lin-Yu Lu,et al.  BRCA1 and homologous recombination: implications from mouse embryonic development , 2020, Cell & Bioscience.

[16]  Jia Chen,et al.  LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling , 2020, Journal of biochemical and molecular toxicology.

[17]  Zhe Zhang,et al.  Exosome‐mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer , 2020, Journal of cellular physiology.

[18]  A. Lyakhovich,et al.  DNA damage response and resistance of cancer stem cells. , 2020, Cancer letters.

[19]  Ping Li,et al.  Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1 , 2020, Bioengineered.

[20]  T. Tong,et al.  HnRNP F/H associate with hTERC and telomerase holoenzyme to modulate telomerase function and promote cell proliferation , 2019, Cell Death & Differentiation.

[21]  Lunquan Sun,et al.  Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis , 2019, Front. Cell Dev. Biol..

[22]  C. Pan,et al.  LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  W. Sakai,et al.  Mechanism and regulation of DNA damage recognition in nucleotide excision repair , 2019, Genes and Environment.

[24]  J. Pascal.  The comings and goings of PARP-1 in response to DNA damage. , 2018, DNA repair.

[25]  Lijun Li,et al.  Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  M. Baretti,et al.  DNA mismatch repair in cancer , 2018, Pharmacology & therapeutics.

[27]  Min Su,et al.  LncRNAs in DNA damage response and repair in cancer cells , 2018, Acta biochimica et biophysica Sinica.

[28]  Jianbo Gao,et al.  TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis , 2018, Cell & Bioscience.

[29]  Yan Peng,et al.  LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway , 2017, Oncotarget.

[30]  A. Davis,et al.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer , 2017, Cancers.

[31]  K. Masuda,et al.  RNA Binding Proteins and Genome Integrity , 2017, International journal of molecular sciences.

[32]  D. Schiffer,et al.  Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma , 2017, Cancers.

[33]  M. Lieber,et al.  Non-homologous DNA end joining and alternative pathways to double-strand break repair , 2017, Nature Reviews Molecular Cell Biology.

[34]  D. Shen,et al.  Long noncoding RNA BLACAT1 indicates a poor prognosis of colorectal cancer and affects cell proliferation by epigenetically silencing of p15 , 2017, Cell Death & Disease.

[35]  Yufeng Yuan,et al.  Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma , 2017, Journal of Experimental & Clinical Cancer Research.

[36]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[37]  F. Setién,et al.  Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer , 2016, Proceedings of the National Academy of Sciences.

[38]  S. Aerts,et al.  p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity , 2016, Nature Medicine.

[39]  V. Timmerman,et al.  The hnRNP family: insights into their role in health and disease , 2016, Human Genetics.

[40]  Mihoko Kai.  Roles of RNA-Binding Proteins in DNA Damage Response , 2016, International journal of molecular sciences.

[41]  D. Matei,et al.  NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer , 2016, Oncogene.

[42]  G. Spivak.  Nucleotide excision repair in humans. , 2015, DNA repair.

[43]  C. Walsh.  Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. , 2015, Gynecologic oncology.

[44]  C. Sette,et al.  The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability , 2015, Front. Genet..

[45]  M. Kastan,et al.  The DNA damage response: implications for tumor responses to radiation and chemotherapy. , 2015, Annual review of medicine.

[46]  C. Chiu,et al.  YB-1 disrupts mismatch repair complex formation, interferes with MutSα recruitment on mismatch and inhibits mismatch repair through interacting with PCNA , 2014, Oncogene.

[47]  Yifeng Zhou,et al.  Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. , 2014, Gastroenterology.

[48]  S. Vagner,et al.  DNA damage: RNA-binding proteins protect from near and far. , 2014, Trends in biochemical sciences.

[49]  V. Evdokimova,et al.  The proteolytic YB-1 fragment interacts with DNA repair machinery and enhances survival during DNA damaging stress , 2013, Cell cycle.

[50]  O. Schärer.  Nucleotide excision repair in eukaryotes. , 2013, Cold Spring Harbor perspectives in biology.

[51]  G. Biamonti,et al.  Pre-mRNA processing factors meet the DNA damage response , 2013, Front. Genet..

[52]  J. Turchi,et al.  Chemotherapy induced DNA damage response , 2013, Cancer biology & therapy.

[53]  S. Fulda.  Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers. , 2012, Cancer Treatment Reviews.

[54]  Peter Bouwman,et al.  The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance , 2012, Nature Reviews Cancer.

[55]  R. Schneider,et al.  mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. , 2012, Molecular cell.

[56]  A. Ashworth,et al.  The DNA damage response and cancer therapy , 2012, Nature.

[57]  C. Pears,et al.  The role of ADP-ribosylation in regulating DNA double-strand break repair , 2012, Cell cycle.

[58]  D. Bartel,et al.  Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution , 2011, Cell.

[59]  Mihee M. Kim,et al.  Global dissociation of HuR–mRNA complexes promotes cell survival after ionizing radiation , 2011, The EMBO journal.

[60]  E. Kolker,et al.  Competition between PARP-1 and Ku70 control the decision between high-fidelity and mutagenic DNA repair. , 2011, DNA repair.

[61]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[62]  P. Howe,et al.  Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles. , 2010, RNA.

[63]  Kotb Abdelmohsen,et al.  Regulation of HuR by DNA Damage Response Kinases , 2010, Journal of nucleic acids.

[64]  J. Rinn,et al.  Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs , 2010, Nature Biotechnology.

[65]  D. Ferraris,et al.  Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. , 2010, Journal of medicinal chemistry.

[66]  W. Lam,et al.  The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1 , 2009, Oncogene.

[67]  Andrei Seluanov,et al.  DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells , 2008, Cell cycle.

[68]  C. Leonetti,et al.  Che-1 activates XIAP expression in response to DNA damage , 2008, Cell Death and Differentiation.

[69]  C. Leonetti,et al.  Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. , 2006, Cancer cell.

[70]  Stephen P. Jackson,et al.  hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage , 2005, Cell.

[71]  Han-Woong Lee,et al.  Extratelomeric functions of telomerase. , 2005, Current molecular medicine.

[72]  G. Salvesen,et al.  XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs , 2005, The EMBO journal.

[73]  P. Johnston,et al.  The role of BRCA1 in the cellular response to chemotherapy. , 2004, Journal of the National Cancer Institute.

[74]  Zhao-Qi Wang,et al.  Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks , 2004, Oncogene.

[75]  M. Lebel,et al.  YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins. , 2004, Nucleic acids research.

[76]  M. Gorospe,et al.  RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[78]  G. Khoury,et al.  p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Lei Li,et al.  Knockdown of Long Noncoding RNA Small Nucleolar RNA Host Gene 12 Inhibits Cell Growth and Induces Apoptosis by Upregulating miR-138 in Nonsmall Cell Lung Cancer. , 2017, DNA and cell biology.

[80]  M. Shekhar,et al.  Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance. , 2015, Mutation research. Reviews in mutation research.